Compare WS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WS | RXRX |
|---|---|---|
| Founded | 1955 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2023 | 2021 |
| Metric | WS | RXRX |
|---|---|---|
| Price | $37.76 | $3.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $42.50 | $7.50 |
| AVG Volume (30 Days) | 200.4K | ★ 17.6M |
| Earning Date | 03-25-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $3,443,800,000.00 | $74,681,000.00 |
| Revenue This Year | $16.77 | $12.11 |
| Revenue Next Year | $2.69 | $82.52 |
| P/E Ratio | $224.59 | ★ N/A |
| Revenue Growth | 11.33 | ★ 26.92 |
| 52 Week Low | $27.22 | $2.77 |
| 52 Week High | $49.17 | $7.18 |
| Indicator | WS | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.21 | 54.57 |
| Support Level | $38.01 | $2.87 |
| Resistance Level | $39.02 | $4.03 |
| Average True Range (ATR) | 1.79 | 0.15 |
| MACD | 0.36 | 0.04 |
| Stochastic Oscillator | 79.72 | 82.14 |
Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.